Company profile
Synartro company profile
Synartro is a Swedish research and development company that develops improved treatments using patented delivery technology combined with existing proven drugs. The preclinical lead program, SYN321, is based on a novel therapy combining diclofenac covalently bound to hyaluronan for the treatment of osteoarthritis (OA), a disease that today leaves up to 50% of patients without adequate pain relief. The company’s initial focus is in knee OA with the potential of further expansion.
Business identity
- Website
- http://synartro.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia
- Postal code
- 754 37
- Country code
- RU
- Continent
- Europe